ASHLEY MILLER: Open Payments
NPI 1154830321 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178,140 in 374 payments from 21 companies in 2025. Trend: 2023 $23,063 · 2024 $121,987 · 2025 $178,140
Speaker / faculty: $136,993Travel & lodging: $28,110Food & beverage: $7,916Consulting: $5,115Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 88 | $68,189 |
| Amgen Inc. | 76 | $48,307 |
| UCB, Inc. | 70 | $41,747 |
| Galderma Laboratories, L.P. | 45 | $16,850 |
| Regeneron Healthcare Solutions, Inc. | 14 | $1,518 |
| Novartis Pharmaceuticals Corporation | 13 | $353 |
| GENZYME CORPORATION | 9 | $339 |
| ABBVIE INC. | 23 | $279 |
| LEO Pharma Inc. | 7 | $168 |
| Lilly USA, LLC | 4 | $82 |
Products named: TREMFYA, Bimzelx, OTEZLA, NEMLUVIO, AKLIEF, DUPIXENT, SKYRIZI, RINVOQ.
Industry payments across FL — which companies pay providers there.
